A recurrent germline BAP1 mutation and extension of the BAP1 tumor predisposition spectrum to include basal cell carcinoma.
about
High incidence of somatic BAP1 alterations in sporadic malignant mesotheliomaUpdate in genetic susceptibility in melanomaConsensus report of the 2015 Weinman International Conference on MesotheliomaThe genetics of uveal melanoma: current insightsLoss of BAP1 Expression Occurs Frequently in Intrahepatic CholangiocarcinomaLoss of expression of BAP1 is a useful adjunct, which strongly supports the diagnosis of mesothelioma in effusion cytologyGermline BAP1 mutation in a family with high incidence of multiple primary cancers and a potential gene-environment interactionLatest developments in our understanding of the pathogenesis of mesothelioma and the design of targeted therapiesComprehensive review of BAP1 tumor predisposition syndrome with report of two new casesBAP1 hereditary cancer predisposition syndrome: a case report and review of literatureMesothelioma: recent highlights.BAP1, a tumor suppressor gene driving malignant mesothelioma.Melanoma genetics.Molecular characterization of melanoma cases in Denmark suspected of genetic predispositionGenomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapyBap1 Is a Bona Fide Tumor Suppressor: Genetic Evidence from Mouse Models Carrying Heterozygous Germline Bap1 Mutations.Clinical features of multiple primary carcinomas of the oral cavity.Germline BAP1 alterations in familial uveal melanoma.BAP1 mutations in high-grade meningioma: implications for patient care.Malignant Mesothelioma: Time to Translate?Ubiquitin recognition of BAP1: understanding its enzymatic function.Genotypic and Phenotypic Features of BAP1 Cancer Syndrome: A Report of 8 New Families and Review of Cases in the Literature.Utility of BRCA1-associated protein 1 immunoperoxidase stain to differentiate benign versus malignant mesothelial proliferations in cytologic specimens.Germline mutations in candidate predisposition genes in individuals with cutaneous melanoma and at least two independent additional primary cancers.Detecting germline BAP1 mutations in patients with peritoneal mesothelioma: benefits to patient and family members.BAP1 acts as a tumor suppressor in intrahepatic cholangiocarcinoma by modulating the ERK1/2 and JNK/c-Jun pathways
P2860
Q24170431-07B55749-EA13-4624-88F2-A8460A950B11Q26778756-3C9768E3-BEB3-4DAD-836E-42414BABE5CFQ27908468-60C7368E-4AF9-4B58-BB82-B2708BFA3F04Q28073150-07CB10F1-F7CD-44E1-97F4-EE11DFF0361BQ28384496-8B2EF388-864E-45AE-940B-C8D95B6AF7ABQ28387556-890648B7-156A-4144-9BED-403C041D1B44Q28393257-35C81686-AB7E-4F33-8B79-581FA9EA5F4BQ28395597-D3087653-DBF3-423D-9D92-718FECCCF60CQ28397229-7CF97BD0-077E-4DC4-9166-7F18ACC982C3Q28397624-AB08E723-DA26-4E1E-8158-897B3D734DFCQ33871606-CD62EEDB-5AA3-4CFF-BC25-0B3399A04165Q33890512-67856B47-4C70-4128-95E5-EDCF668E90ABQ34044830-392816B7-2C87-46A4-B04C-BC0347C65B51Q35213835-8F28BAC3-A774-48A0-87E7-FAE4B6EFD492Q36755569-851C507E-2F72-4C1A-9227-BE61BF6765B8Q36918087-F9647F3D-245B-4BC0-ADFE-4D54EE2D0ABCQ37697646-E535E8C8-AC34-4203-BC42-1F7BD8F74BEDQ38805682-12C337CF-CC97-4EEA-B004-1946538866BBQ39290955-510AC63A-5D9B-458C-815D-E3FECD707BF5Q39366003-7CCBE6C6-5C7B-4FB5-A4D1-624B5E1090CCQ47155655-D8548869-CCE1-45C2-B18A-7A65DD43CB43Q47972869-3E85B16F-6652-4C0E-9739-AF637C524D60Q48230081-80A02D0B-61B0-4DA2-8170-928315352BFAQ54116561-AE61CE81-CB0E-487A-8B44-6F08286AFACDQ55665416-63CBC3C1-2EBC-4E70-BA3A-515A8A05A9F8Q57283068-DC52ABAA-809A-4431-95E1-94CD21CFBC04
P2860
A recurrent germline BAP1 mutation and extension of the BAP1 tumor predisposition spectrum to include basal cell carcinoma.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
A recurrent germline BAP1 muta ...... include basal cell carcinoma.
@en
A recurrent germline BAP1 muta ...... include basal cell carcinoma.
@nl
type
label
A recurrent germline BAP1 muta ...... include basal cell carcinoma.
@en
A recurrent germline BAP1 muta ...... include basal cell carcinoma.
@nl
prefLabel
A recurrent germline BAP1 muta ...... include basal cell carcinoma.
@en
A recurrent germline BAP1 muta ...... include basal cell carcinoma.
@nl
P2093
P2860
P50
P356
P1433
P1476
A recurrent germline BAP1 muta ...... include basal cell carcinoma.
@en
P2093
B Federspiel
J F Thompson
K A W Wadt
P2860
P304
P356
10.1111/CGE.12501
P50
P577
2014-11-06T00:00:00Z